Caption Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.6M Buy
+115,183
New +$11.6M 0.06% 311
2025
Q2
Sell
-8,930
Closed -$399K 1630
2025
Q1
$380K Buy
+8,930
New +$385K ﹤0.01% 1161
2024
Q4
Sell
-12,248
Closed -$281K 1593
2024
Q3
$281K Sell
12,248
-6,711
-35% -$190K ﹤0.01% 1020
2024
Q2
$548K Buy
18,959
+13,959
+279% +$325K 0.01% 794
2024
Q1
$103K Sell
5,000
-5,800
-54% -$124K ﹤0.01% 1056
2023
Q4
$292K Buy
+10,800
New +$283K ﹤0.01% 1065
2023
Q2
Sell
-5,600
Closed -$131K 1218
2023
Q1
$131K Sell
5,600
-43,745
-89% -$1.25M ﹤0.01% 950
2022
Q4
$1.34M Buy
49,345
+35,651
+260% +$1.63M 0.02% 656
2022
Q3
$738K Sell
13,694
-82,486
-86% -$4.23M 0.01% 970
2022
Q2
$3.88M Buy
96,180
+67,090
+231% +$3.32M 0.05% 443
2022
Q1
$1.93M Buy
+29,090
New +$1.99M 0.02% 773
2020
Q1
Sell
-52,834
Closed -$4.13M 932
2019
Q4
$4.13M Buy
+52,834
New +$3.81M 0.14% 205

Other funds holding GH

Caption Management's GH Position: Q1 2026 in Review

Caption Management opened a new position in Guardant Health (GH) in Q1 2026: 115,183 shares worth $10.6M. The stake represents 0.06% of the portfolio and ranks #311 among its holdings. This is a return to the name: Caption Management previously reported a position in GH as recently as Q1 2025.

Caption Management first reported a position in GH in Q4 2019 and has held it in 12 quarters since. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Caption Management held 115,183 shares of Guardant Health worth $10.6M as of Q1 2026.
  • Guardant Health was a new Caption Management position in Q1 2026.
  • Guardant Health made up 0.06% of Caption Management's portfolio in Q1 2026, its #311 holding.
  • Caption Management first reported a position in Guardant Health in Q4 2019 and has held it in 12 quarters since.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.